Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Human TL1A-DR3 inhibition Kit (TR-FRET)

Human TL1A-DR3 inhibition Kit (TR-FRET) is expressed from Human

Product Specifications

Background

TNF-like cytokine 1A (TL1A) and its receptors, death receptor 3 (DR3) and decoy receptor 3 (DcR3) are members of the TNF and TNF receptor superfamilies of proteins, respectively. Binding of APC-derived TL1A to lymphocytic DR3 provides co-stimulatory signals for activated lymphocytes. DR3 signaling affects not only the proliferative activity of and cytokine production by effector lymphocytes, but also critically influences the development and suppressive function of regulatory T-cells. Whereas, DcR3 restricts the function of the TL1A/DR3 complex: attenuating T-cell activation and downregulating the secretion of pro-inflammatory cytokines. Together with DR3 and DcR3, TL1A constitutes a cytokine system that actively interferes with the regulation of immune responses. The Human TL1A-DR3 Binding Kit (TR-FRET) can detect the binding of TL1A to DR3 in homogeneous system within 0.5-1 hours. it is high sensitive, short detection time and easy to use.

Reactivity

Human

Target

TL1A-DR3

Applications

The kit is developed for the binding of TL1A to the DR3.

Stability

1. Store the unopened kit at 2-8°C upon receipt. 2. Locate the expiration date on the outer packaging and do not use reagents beyond their expiration date. 3. The opened kit should be stored according to the storage conditions listed in the Components Table. The shelf life of the opened kit is 30 days from the date of opening.

Format

Solid

Components

This Human TL1A-DR3 inhibition kit (TR-FRET) is based on TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer) . Use a mixture of biotinylated human TL1A and Europium-chelate labeled streptavidin as the donor and FA labeled human DR3 protein as the acceptor. - In the absence of inhibitors for human TL1A binding to human DR3, the donor and acceptor are in close proximity due to the binding of human TL1A and FA-labeled human DR3. Upon excitation with a specific light source, the donor emits a 620 nm signal, which is absorbed by the acceptor, resulting in a 665 nm emission. - In the presence of inhibitors that block the binding of human TL1A to human DR3, the donor-acceptor interaction is disrupted, preventing FRET from occurring.

Additionnal Information

Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments

Shipping Conditions

Blue ice

Storage Conditions

2-8°C

Package Size

500tests*20

Species

Human

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Phospho-CBL (Ser804) Antibody
AF7263-01 100 µL

Phospho-CBL (Ser804) Antibody

Ask
View Details
Phospho-CBL (Ser804) Antibody
AF7263-02 200 µL

Phospho-CBL (Ser804) Antibody

Ask
View Details
CHRNB3 Recombinant Protein Antigen
NBP1-91783PEP 0.1 mL

CHRNB3 Recombinant Protein Antigen

Ask
View Details
GRAP2 Over-expression Lysate Product
GWB-A091B6 0.1 mg

GRAP2 Over-expression Lysate Product

Ask
View Details
Rat NXPH1 siRNA
abx926696-01 15 nmol

Rat NXPH1 siRNA

Ask
View Details
Rat NXPH1 siRNA
abx926696-02 30 nmol

Rat NXPH1 siRNA

Ask
View Details